AstraZeneca turns to India again; strikes licensing pact with Aurobindo
This article was originally published in Scrip
Executive Summary
Aurobindo Pharma of India has entered into a licensing deal with AstraZeneca for the supply of a range of solid dosage and sterile products for emerging markets. The agreement comes months after AstraZeneca struck a similar alliance with India's Torrent Pharmaceuticals to propel its emerging markets business.